Medpace Holdings, Inc.
MEDPUS売上高
$2.5B
百万USD
営業利益
$535M
百万USD
純利益
$451M
百万USD
ROE
98.3%
最新FY
EPS
$15.28
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $260M | $43M | $1.14 |
| FY2021 | Q2 | $278M | $40M | $1.06 |
| FY2021 | Q3 | $296M | $49M | $1.29 |
| FY2021 | FY | $1.1B | $182M | $4.81 |
| FY2022 | Q1 | $331M | $61M | $1.69 |
| FY2022 | Q2 | $351M | $49M | $1.46 |
| FY2022 | Q3 | $384M | $66M | $2.05 |
| FY2022 | FY | $1.5B | $245M | $7.28 |
| FY2023 | Q1 | $434M | $73M | $2.27 |
| FY2023 | Q2 | $461M | $61M | $1.93 |
| FY2023 | Q3 | $492M | $71M | $2.22 |
| FY2023 | FY | $1.9B | $283M | $8.88 |
| FY2024 | Q1 | $511M | $103M | $3.20 |
| FY2024 | Q2 | $528M | $88M | $2.75 |
| FY2024 | Q3 | $533M | $96M | $3.01 |
| FY2024 | FY | $2.1B | $404M | $12.63 |
| FY2025 | Q1 | $559M | $115M | $3.67 |
| FY2025 | Q2 | $603M | $90M | $3.10 |
| FY2025 | Q3 | $660M | $111M | $3.86 |
| FY2025 | FY | $2.5B | $451M | $15.28 |
| FY2026 | Q1 | $707M | $124M | $4.28 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $705M | $861M | $926M | $1.1B | $1.5B | $1.9B | $2.1B | $2.5B |
| 営業利益 | $52M | $65M | $101M | $127M | $167M | $199M | $279M | $337M | $447M | $535M |
| 純利益 | $13M | $39M | $73M | $100M | $145M | $182M | $245M | $283M | $404M | $451M |
| 総資産 | $979M | $951M | $968M | $1.1B | $1.4B | $1.7B | $1.4B | $1.7B | $2.1B | $2.0B |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $611M | $504M | $590M | $726M | $806M | $953M | $386M | $559M | $826M | $459M |
| 営業CF | - | - | $157M | $202M | $259M | $263M | $388M | $433M | $609M | $713M |
| EPS | $0.37 | $0.98 | $1.97 | $2.67 | $3.84 | $4.81 | $7.28 | $8.88 | $12.63 | $15.28 |
| BPS | $14.99 | $14.19 | $16.52 | $20.12 | $22.55 | $27.05 | $12.44 | $18.17 | $27.10 | $16.18 |
| ROE | 2.2% | 7.8% | 12.4% | 13.8% | 18.0% | 19.1% | 63.5% | 50.6% | 49.0% | 98.3% |